Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-26 @ 2:34 AM
NCT ID:
NCT02856802
Population Description:
A maximum 21 day screening period was conducted to evaluate whether a subject met the migraine inclusion criteria pursuant to ICHD-3, and did not exhibit medication overuse. If eligible and randomized, subjects in the DB1 treatment period were instructed to use the study medication for their first migraine attack as soon as (and no more than 1 hour after) experiencing moderate to severe migraine pain. If the subject was missed dosing the first migraine, they were to dose the next attack.
Study:
NCT02856802
Study Brief:
Results Section:
NCT02856802